Selected article for: "average mortality and mortality rate"
Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
  • Document date: 2018_2_27
    • ID: t9tysvr8_55
    Snippet: The average mortality rate of RSV-LRTI is 32% (range, 0% to 70%) in international studies, and the major risk factors for progression to LRTI are lymphopenia, old age, mismatched/unrelated donor, and neutropenia [128, 129] . In cases of PIV-LRTI, the overall mortality rate is 10% to 30%, and high-level corticosteroid exposure, neutropenia, lymphopenia, and early onset after HSCT are the major risk factors for LRTI [129] [130] [131] . The rate of .....
    Document: The average mortality rate of RSV-LRTI is 32% (range, 0% to 70%) in international studies, and the major risk factors for progression to LRTI are lymphopenia, old age, mismatched/unrelated donor, and neutropenia [128, 129] . In cases of PIV-LRTI, the overall mortality rate is 10% to 30%, and high-level corticosteroid exposure, neutropenia, lymphopenia, and early onset after HSCT are the major risk factors for LRTI [129] [130] [131] . The rate of progression of influenza to LRTI is 25% to 28% and the overall mortality rate is 25% to 58% [132] [133] [134] . The risk factors for progression to influenza-LRTI are early onset after HSCT, lymphopenia, old age, neutropenia, and delayed antiviral administration [132] [133] [134] . In cases of rhinovirus, most infections are asymptomatic, less than 10% of patients progress to definite pneumonia, and the mortality rate is < 10% [135, 136] . In addition, human metapneumovirus, adenovirus, coronavirus, and bocavirus can cause URTIs and LRTIs in HSCT patients [129, 137] .

    Search related documents:
    Co phrase search for related documents
    • antiviral administration and mortality rate: 1, 2, 3, 4, 5, 6, 7
    • corticosteroid exposure and mortality rate: 1
    • early onset and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • early onset and international study: 1, 2, 3, 4, 5
    • high level and international study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • influenza LRTI progression and LRTI progression: 1
    • influenza progression and LRTI progression: 1, 2